RXO Reports Significant Q4 Loss, Weak Q1 Outlook, and Replaces $600M Unsecured Revolver with Smaller $450M Asset-Based Facility
Summary
RXO reported a significant Q4 2025 financial decline and issued a weak Q1 2026 outlook, while also replacing its larger unsecured credit facility with a smaller, asset-based one, reflecting tighter financial conditions and operational headwinds.
Key Events
-
Significant Q4 2025 Financial Decline
RXO reported Q4 2025 revenue of $1.5 billion (down from $1.7 billion YoY), a GAAP net loss of $46 million (vs. $25 million loss YoY), and adjusted EBITDA of $17 million (down from $42 million YoY).
-
Weak Q1 2026 Outlook
The company provided an adjusted EBITDA outlook for Q1 2026 between $5 million and $12 million, with brokerage volume expected to decline by 5% to 10% year-over-year.
-
Credit Facility Restructuring
RXO finalized a new $450 million asset-based revolving credit facility, replacing its previous $600 million unsecured revolving credit facility. This reduces total available credit and shifts to a more restrictive financing structure.
-
Goodwill Impairment Recorded
The company recorded a $12 million goodwill impairment related to the restructuring of its ground and air express service offering within its Managed Transportation business.
Analysis
RXO, Inc. reported a substantial decline in its fourth-quarter 2025 financial performance, with revenue falling to $1.5 billion from $1.7 billion year-over-year and adjusted EBITDA dropping significantly to $17 million from $42 million. The company also provided a weak outlook for Q1 2026, projecting adjusted EBITDA between $5 million and $12 million, indicating continued operational challenges and a tightening freight market. Concurrently, RXO finalized a new $450 million asset-based revolving credit facility, replacing its previous $600 million unsecured revolving credit facility. While the company highlights improved pricing and flexibility, this represents a reduction in total available credit and a shift to a more restrictive asset-based lending structure, which can signal increased lender caution. The $12 million goodwill impairment further underscores the operational difficulties. These combined factors suggest a challenging period ahead for the company, likely leading to negative investor sentiment.
At the time of this filing, RXO was trading at $15.24 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $10.43 to $25.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.